Logo

1st PGIVAC

1st PGIVAC

27th to 31th July 2016
Department of Community Medicine, School of Public Health, PGIMER


TECHNICAL PROGRAM


Time
Topic
Presenter
Day 1: 27/7/2016 Module 1: Introduction and History of Vaccine development
8.00 to 9:00 am Registration  
9.00 to 9.30 am Inauguration
Welcome Address Key note addresses Introduction to course Description of course objectives and Vote of Thanks		   Dr Rajesh Kumar, Prof and Head, SPH, PGIMER
Dr YK Chawla, Director, PGIMER
Dr Subhash Varma, Dean, PGIMER
Dr Rajesh Kumar, Prof and Head, SPH, PGIMER
Dr Madhu Gupta, Adl. Prof, SPH, PGIMER
9:30 – 10:00 am Tea Break
10:00 – 10:30 am Introduction of participants. Dr Madhu Gupta, Adl. Prof, SPH, PGIMER
10:30 – 11:00 am History of vaccines and vaccination Dr Rajesh Kumar, Prof and Head, SPH, PGIMER
11:00 -11:30 am Case study: Small pox eradication
11:30 – 12:00 pm Role of disease burden assessment in the decision making process Dr Vikas Bhatia, Dean, AIIMS Bhubaneswar.
12:00- 12:30 pm Impact of vaccination on disease epidemiology:  strategies to control, eliminate and eradicate vaccine preventable diseases Dr PVM lakshmi, Adl. Prof, SPH, PGIMER
12:30 – 1:00 pm Polio vaccination-endgame to eradication Dr Shivani Gupta, Surveillance Medical Officer, WHO
1:00 – 1:30 pm Challenges and solutions in making evidence based national vaccination policies Dr Gagandeep Kang, Prof & head, The welcome trust research laboratory, CMC Vellore 
1:30-2:00 pm The role of vaccine industry in the development of Vaccine Dr Badri Narayan Patnaik, Sr. General Manager, Head-Clinical R&D, Shantha Biotech, A Sanofi Company
2:00 -3:00 pm Lunch break  
3:00 – 4:00 pm PUBLIC HEALTH LECTURE in Lecture Theatre-1, Nehru Building, PGIMER Dr MK Bhan, National Science Professor, IIT, Delhi, Former Secretary, GOI, DBT, MOS&T
4:00 – 4:30 pm Tea break  
4:30 – 5:00 pm Group allocation  
Day 2: 28/07/2016 Module 2: Immunology related to Vaccines
8.30 to 9.00 am Recap of Day 1  
9:00 – 10:00 am What vaccinologist should know about basic aspects of immune response: Innate, Cell mediated and humoral immune response Dr Biman Saikia, Professor Immunopathology, PGIMER
10:00 – 11:00 am Primary and secondary immune responses: role of boosters
Immunological memory: the challenge of conferring long term protection		 Dr Arun Bansal, Adl Professor Paediatrics, PGIMER
11:00 – 11:30 am Tea break  
11:30 – 12:30 pm Vaccines affecting innate and humoral immune responses Dr Ashwini K Sood, Prof, and head, Paediatrics, IGMC Shimla
12:30 -1:30 pm Vaccination in immune-compromised individuals including HIV positive and pregnant women Dr Rajesh Kumar, Prof and Head, SPH, PGIMER
1:30 – 2:30 pm Lunch break  
2:30 – 3:30 pm Vaccines affecting cell mediated immunity and special cases Dr Ritu Aggarwal, Adl. Prof, Immunopathology, PGIMER
3:30 – 4:00 pm Tea break  
4:00 – 5:30 pm Group exercise: Rotavirus vaccine development (Immunology) Group 1: Dr Biman Saikia
Group 2: Dr Arun Bansal
Group 3: Dr Ritu Aggarwal
Group 4: Dr Sanjay Varma
Group 5: Dr Rajesh Kumar
Group 6: Dr Madhu Gupta
Day 3: 29/07/2016 Module 3: Regulations and Ethics and phases of Vaccine development
8.30 to 9.00 am Recap of Day 2  
9:00 – 10:00 am Regulations and Ethical considerations related to vaccine trials Mr Anant Bhan, Senior manager, IAVI
10:00 – 10:30 am Group exercise: Ethical issues in vaccine development
10:30 – 11:00 am Tea break  
11:00 – 11:30 am Preclinical safety testing of vaccines Dr Nusrat Shafiq, Adl. Prof, Pharmacology, PGIMER
11:30 – 12:00 am Introduction to statistical aspects of clinical trial (Defining sample size: practical approaches and example) Dr PVM lakshmi, Adl. Prof, SPH, PGIMER
12:00 –02:00 pm Case Study of development of a vaccine from laboratory to the community.
Phase I vaccine trials:
Phase II vaccine trials: Efficiency studies
Phase III vaccine trials: Effectiveness studies 		SAS Team, New Delhi
Dr Nita Bhandari, Director
Dr Temsunaro Rongsen, Research Scientist
Dr Nidhi Goyal, Research Scientist
2:00 – 3:00 pm Lunch break  
3:00 –4:00 pm Group exercise: How to design, recruit and analyze the results of phase I/II trials of rotavirus vaccine Group 1: Dr Nusrat Shafiq
Group 2: Dr Nita Bhandari
Group 3: Dr Nidhi Goyal
Group 4: Dr Sanjay Verma
Group 5: Dr Temsunrao Rongsen
Group 6: Dr Madhu Gupta
4:00 – 4:30 pm Tea break  
4:30 – 5:30 pm Group exercise: How to design, recruit and analyze the results of phase III trials of rotavirus vaccine Group 1: Dr Nusrat Shafiq
Group 2: Dr Nita Bhandari
Group 3: Dr Nidhi Goyal
Group 4: Dr Sanjay Verma
Group 5: Dr Temsunrao Rongsen
Group 6: Dr Madhu Gupta
Day 4: 30/07/2016 Module 4: Introduction of vaccines in National Immunization Programs
8.30 to 9.00 am Recap of Day 3  
9:00 – 9:45 am National Vaccine Policy: India Dr N.K. Ganguly, Former Director, ICMR
09:45 – 10:30 am Rationale for introducing new vaccine in the immunization program; and challenges in its implementation Dr Chandrakant Lahariya, National Professional Officer, WHO
10:30 – 11:00 am Assessing herd protection and vaccine effectiveness Dr Madhu Gupta, Adl. Prof, SPH, PGIMER
11:00 – 11:30 am Tea break  
11:30 – 12:30 pm Health economics as a tool in analyzing vaccine policy option Dr Shankar Prinja, Assoc. Prof, SPH, PGIMER
12:30 – 1:30 pm Group exercise: Rationale and decision making for rotavirus vaccine introduction in national immunization program (review of cost effectiveness studies) Group 1: Dr Tarundeep Singh
Group 2: Dr Shankar Prinja
Group 3: Dr PVM Lakshmi
Group 4: Dr Sanjay Verma
Group 5: Dr Satish Gupta
Group 6: Dr Madhu Gupta
1:30 – 2:30 pm Lunch break  
2:30 - 3.00 pm Ethical considerations regarding implementation of vaccine in organized program Dr Anu Chopra Dosajh, District Immunization Officer, Chandigarh
3.00-4.00 pm Procurement of vaccines: Role of GAVI, WHO, UNICEF Dr Satish Gupta,Health specialist, UNICEF
4:00 – 4:30 pm Tea break  
4:30-5:30 pm Group exercise: Evidence based vaccination policy in Rotavirus vaccine Group 1: Dr Tarundeep Singh
Group 2: Dr Shankar Prinja
Group 3: Dr PVM Lakshmi
Group 4: Dr Sanjay Verma
Group 5: Dr Rajesh Kumar
Group 6: Dr Madhu Gupta
Day 5: 31/07/2016 Module 5: Update on Current and Newer Vaccines
8.30 to 9.00 am Recap of Day 4
9:00 – 10:00 am Licensed vaccines: Rotavirus vaccine, MMR/MR, IPV, Pentavalent Dr Sanjay Varma, Adl. Prof, Paediatrics, PGIMER
10:00 – 11:00 am Licensed Vaccines: HPV for cervical cancer, Pneumococcal vaccines for pneumonia, Shancol for cholera, Hepatitis A vaccine, Influenza vaccines Dr Ashish Bhalla, Prof, Internal Medicine, PGIMER
11:00 – 11:30 am Tea break  
11:30 – 1:00 pm Vaccines in development phase: HIV/AIDS, TB and malaria vaccines, Dengue Dr Vikas Suri, Adl. Prof, Internal Medicine, PGIMER
1:00 – 2:00 pm Lunch break  
2:00 – 4:00 pm Participant’s presentation of Group Work Group Facilitators
4:00 – 4:30 pm Valedictory  
4:30 – 5:00 pm Tea